| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |